Introduction. Fungal keratitis is a severe condition which may lead to blindness. Fungal keratitis, also known mycotic keratitis or keratomycosis, has worldwide distribution, but is more common in tropical climates compared to moderate zones. In recent years, there have been several studies suggesting an increase in the number of mycotic keratitis cases in countries with a moderate climate. There is little data available with no literature review concerning fungal keratitis in European countries. Objective. To analyse the causes, presentation, and clinico-pathological associations of fungal keratitis in a retrospective series of patients referred to the Department of Ophthalmology of the Railway Hospital in Katowice, south-west Poland, and comparing the findings to previously published studies in peer reviewed articles from other European countries published between 2000-2019. Materials and method. Data were collected using the medical records of patients with fungal keratitis. Risk factors, clinical manifestation and treatment results were analysed from 45 patients (45 eyes) with fungal keratitis treated in the Department of Ophthalmology of Railway Hospital in Katowice between January 2013 -December 2017. The factors affecting the development of infection, visual acuity at baseline and at the end of treatment, as well as treatment method selection, were analysed. Literature review was performed using the Medline, Pubmed, Embase databases and Google scholar. The inclusion criteria were peer reviewed papers published between 2000-2019 which reported data from patients with fungal keratitis in at least one European country. 11 peer reviewed articles which matched the inclusion criteria were analysed. Results. The mean BCVA of patients treated in the Department of Ophthalmology of the Railway Hospital in Katowice upon diagnosis was 2.3 (logMAR), compared to 1.95 (logMAR) at the end of treatment. Pearson's chi-squared test was used to establish the final mean BCVA in eyes with keratitis caused by Candida spp. compared with keratitis caused by Filamentous spp. The reviewed articles showed poor results of treatment and diagnostic difficulties in fungal keratitis. Conclusions. Fungal keratitis is a significant diagnostic and therapeutic challenge and may occur in rural and urban areas. Early and accurate diagnosis followed by proper antifungal treatment can prevent blindness and improve BCVA results.
INTRODUCTION
Fungal keratitis was first reported by Theodor Leber in 1879 in a farmer who sustained ocular trauma when working on his farm. The highest prevalence of fungal keratitis is shown in hot and humid climate zones, where it may constitute 30-62% of all cases of keratitis [1, 2, 3, 4, 5, 6] . However, in recent years, the prevalence of fungal keratitis in moderate climate zones has been increasing [7] . This can be linked to better availability and popularity of contact lenses and, as a result, fungal infections caused by Fusarium spp. The available literature has identified a number of risk factors of fungal infections.
Fungal keratitis poses a significant diagnostic and therapeutic challenge, due to limited diagnostic options, microbial isolation, poor penetration of deeper corneal layers, and the limited number of therapeutic agents available in Poland.
OBJECTIVE
The purpose of this study was to review the causes, presentation, and clinico-pathological associations of fungal keratitis in a retrospective series of patients referred to the Department of Ophthalmology of the Railway Hospital in Katowice, south-east Poland, as well as to compare the findings to previously published studies from other European countries. Patients and study design. The restrospective analysis is presented of 45 patients (45 eyes) with fungal keratitis treated in the Depart9ment of Ophthalmology of the Railway Hospital in Katowice between January 2013 -December 2017.
The study was performed in compliance with the Declaration of Helsinki.
Ophthalmic investigations. All subjects underwent a comprehensive assessment which included medical history, risk factor identification for fungal keratitis, slit lamp examination, confocal microscopy with Rostock Corneal Module on HRT3 (Heidelberg Engineering, Germany), and corneal scrapings (using 23G needle) or conjunctival smear for microbial testing. Depending on lesion location, limbal involvement and the presence of hypopon, a dedicated treatment algorithm was followed involving systemic and topical antifungal agents, subconjunctival, intracorneal, intracameral injections and cross-linking. Corneal graft was performed in eyes not responding to antifungal treatments and those with corneal perforation. The factors affecting the development of infection, visual acuity at baseline and at the end of treatment as well as treatment method selection were analysed.
Literature review of cases of fungal keratitis in Europe.
Literature review was performed using the Medline database and Google scholar. The inclusion criteria were peer reviewed papers published between 2000-2019 which reported observational data from patients with fungal keratitis in at least one European country. The following search terms were used: "fungal keratitis", "keratomycosis", "pattern of fungal keratitis in Europe" and "epidemiology of mycotic keratitis". Ten published articles met the inclusion criteria [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . The literature data was analysed in terms of gender, age, causes of fungal keratitis, and treatment outcomes in order to identify similarities and differences, and to enable further comparisons with the results obtained at the Department of Ophthalmology of the Railway Hospital in Katowice.
Statistical analysis.
To assess the normality of distribution for the available data, the Shapiro-Wilk's test was used. Excel (Office 365) and Statitica 13 bundles were used for calculations and design of graphs and diagrams. Normally distributed variables were reported as a mean and standard deviation (SD). The unpaired student's t-test was used for comparisons between patients with yeast versus filamentous keratitis. Visual acuity was presented as a logMAR scale, assuming a 95% confidence interval (95% CI). Due to the nonnormal distribution of visual acuity on the logMAR scale, the Wilcoxon test was used for the analysis of BCVA values at baseline and at the end of treatment. Pearson's chi-squared test was used for comparing categorical variables between patients with yeast versus filamentous keratitis. The risk factors for fungal keratitis included eye injury involving organic matter (15 cases), wearing contact lenses (10 cases), long-term use of corticosteroids (6 cases), previous ocular surgery (7 cases) and ocular surface disorder, such as dry eye disease secondary to Sjögren's syndrome, blepharitis with Meibomian gland dysfunction, or neurotrophic keratopathy (7 cases). The infectious agents were filamentous fungi -25 cases (55.6%) and yeast -20 cases (44.4%). Among the filamentous fungi, the most often isolated pathogen was Fusarium solani, whereas the most often isolated representative of yeast was Candida albicans. The most common factor associated with fungal infection was eye injury involving organic matter, followed by wearing contact lenses, ocular surface disorder, previous ocular surgery (keratoplasty), and previous use of corticosteroids. Eye injury involving organic matter was the main risk factor in cases of infections caused by Fusarium spp., whereas keratitis caused by Candida albicans occurred more often in patients after previous ocular surgery, as well as those with ocular surface disorder, and -to a less exeten -in contact lens wearers. Microbial analyses confirmed the fungal origin of keratitis in 25 patients (55.6%) with 15 cases (33.3%) of filamentous fungal keratitis and 10 cases (22.2%) caused by yeast. Confocal microscopy demonstrated features of fungal keratitis in 42 cases (93.3%).
RESULTS

Retrospective observational study findings in
The mean BCVA upon diagnosis was 2.3 (logMAR), compared to 1.95 (logMAR) at the end of treatment. The final BCVA was better in eyes with keratitis caused by yeast rather than filamentous fungi. Visual acuity improvement was demonstrated in 24 patients, it remained unchanged in 12 patients and worsened in 9 patients. The mean antifungal treatment duration was 110 days. The end of treatment was defined as a "calm eye", with no signs of inflammation and/ or corneal scarring. Upon this presentation, antifungal treatments were discontinued. The mean follow-up duration was 20 months. Treatment of fungal keratitis significantly affected the visual outcome in the study population (p = 0.04).
The treatment protocol for keratitis caused by filamentous fungi included topical fluconazole (18 eyes) or voriconazole (15 eyes), administered every hour during the day and every 2 hours during the night throughout the first 48 hours. In cases of keratitis caused by yeast, topical amphotericin B was used (12 eyes). Where the corneal inflammatory infiltrate penetrated deep into the stroma or to the anterior chamber, intracorneal (12 eyes) or intracameral (8 eyes) injections of voriconazole, subconjunctival injections of fluconazole (25 eyes) and systemic fluconazole (p.o.) were administered.
Corneal cross-linking was used as an adjunctive to medical treatment in 7 selected cases of limited inflammation with only superficial (below 250 μm) corneal layer involvement. There were 8 cases of corneal perforation, which were treated with keratoplasty. Keratoplasty was also performed in eyes not responding to medical treatment, a total of 19 eyes (42.2%), including 4 eyes after CXL. During each AAEM
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keratoplasty, fluconazole or voriconazole was administered as an intracameral or intracorneal injection. The mean time from the commencement of antifungal treatment to keratoplasty was 16.93 days. Two patients required subsequent corneal graft due to a decompensated primary flap. Fungal keratitis reoccurred in 6 cases. Three of them were effectively treated with targeted antifungal agents, whereas 3 needed keratoplasty. In one male, evisceration was performed due to malacia of the corneal flap with extremely unfavourable vision prognosis. This particular patient had 4 previous corneal grafts. The first penetrating keratoplasty was performed due to post-traumatic ocular perforation, and all subsequent grafts were decompensated. (Fig. 1A) . Image of the same patient's eye one week after PK (Fig. 1B) . HRT III with the Rostock Cornea Module (Heidelberg Engineering, Germany) of Fusarium solani-infected patient's cornea showing high-contrast lines resembling Fusarium hyphae, high-contrast structures consistent with corneal nerves (Fig. 1C ) In European countries with a moderate climate, outbreaks of fungal keratitis are much less common than in tropical areas of Asia, Australia or America [4, 5, 19] . The authors of this article have identified 11 epidemiological studies of fungal keratitis in the United Kingdom, France, Switzerland, Denmark, Germany and Ireland, which discussed such aspects as main risk factors, aetiology, patient age and gender, as well as treatment methods. The results are shown in Table 2 .
DISCUSSION
Although several studies of fungal keratitis in Europe have been published, the literature lacks a retrospective analysis of keratomycosis in Poland. Therefore, the aim of this study is to review the causes, presentation, and clinico-pathological associations of fungal keratitis in the Department of Ophthalmology in Katowice, Poland, in 2013-2017, and to compare the findings with previously published studies conducted in Europe in 2000-2019. The main difference here is that the presented study was a single centre study, whereas the other published data is from multicentre studies carried out in Ireland, United Kingdom, Germany, and Denmark [9, 10, 13, 14, 15 ]. In the current study, as well as in other European countries, the incidence of fungal keratitis was lower than reported by authors from, e.g. China, India or the USA [2, 4, 5] . This is associated with the fact that both in Poland and elsewhere in Europe, e.g. in Germany, United Kingdom, Ireland or Switzerland, fungal infections (including fungal keratisis) are significantly less common than in humid and hot climate zones, where fungi can be reponsible for over 50% of all corneal ulcers [6, 20] . Even though fungal keratitis is not as common in Europe as it is in warmer climates. Hon Shing Ong demonstrated an increase of its incidence rate in the United Kingdom, compared to previous years [13] . The mean age of all patients in the current study was 51.5 years. Interestingly, keratitis caused by filamentous fungi was typically diagnosed in younger patients (mean age 47.7 years) than keratitis caused by Candida spp. (mean age 57.7 years). The mean age of patients reported in the studies from Denmark, Ireland, UK, Switzerland or France ranged between 47.4-63.7 years. In line with currently presented observations, Nielsen confirmed the presence of filamentous fungi as causal pathogens in keratitis in younger patients (mean age 45 years). In the presented study, the main causal pathogen were filamentous fungi, especially Fusarium spp., as opposed to yeast, which were found in previous studies [9, 10] [8, 9, 13, 14, 17, 21] pointed to filamentous fungi as the main infectious agent, with most cases of fungal keratitis caused by The main causes of fungal keratitis in the Department of Ophthalmology in Katowice in 2013-2017 were ocular trauma, followed by contact lens wear, ocular surface disorder, and long-term use of topical corticosteroids, whereas in other European countries, contact lense wear predominated, followed by ocular surface disorder, longterm use of topical corticosteroids, and ocular trauma at the end of the list. Only Tuff mentioned ocular trauma as the main risk factor [10] . This difference can be explained by more common use of contact lenses in these countries compared to Poland, linked to their better economic status. Yeast causing fungal keratitis were mostly isolated in patients with known ocular surface disorders, those after previous ocular surgery (especially keratoplasty), and long-term users of topical corticosteroids. This is in keeping with the results of [9, 10, 12, 13, 14] . In the current study, Fusarium spp. was most often isolated from keratitis associated with ocular trauma and contact lens wear.
In the current study, patients with filamentous infections had significantly worse visual outcomes and were more likely to need a corneal graft than those with Candida infections (56% versus 25%). Hon Shing et al. demonstrated similar results in their study conducted in 2007-2014 in a British population [13] . On the contrary, previous studies from Denmark, Ireland, as well as the United Kingdom, indicated a better prognosis in terms of both the ultimate visual acuity and the need for keratoplasty in eyes with fungal keratitis caused by filamentous fungi. Patients with fungal keratitis were treated in the Department of Ophthalmology in Katowice with topical voriconazole, fluconazole and amphotericin B, with additional oral fluconazole in 30 cases. In other European countries, topical natamycine is used, which is unavailable in Poland. Medical treatment was used in all cases and proved to be sufficient in 26 (57.8%) cases. Corneal cross-linking was performed in 7 patients with limited, superficial inflammation (below 250 μm), in whom a complete response to medical treatment was not achieved. Whereas 3 of the patients responded well to CXL and the inflammation resolved, the remaining 4 (57%) patients needed keratoplasty. In the study by Alio et al., 38 .5% of patients after previous CXL needed keratoplasty in later treatment [22] . The CXL proved to be more effective in bacterial or protozoan keratitis rather than in fungal infections.
In the presented sample, keratoplasty was eventually performed in 19 eyes (42.2%), more often in cases of keratitis caused by filamentous fungi. In the studies by Iselin et al. , the percentage of patients receiving corneal grafts was lower than in the current sample, amounting to 24%, 26.2%, 31.6%, and 24.1%, respectively [8, 12, 13, 14] . Nielsen E (Denmark) and Galarreta ) , however, reported higher keratoplasty rates (52% and 46.2%, respectively) than in the current study [9, 15] . In the Department of Ophthalmology in Katowice, more keratoplasties were performed in patients with infections caused by filamentous fungi than by yeast. Currently, confocal microscopy, a non-invasive method which enables an in vivo histological assessment of individual corneal layers and detection of filaments or oval cells indicative of yeast origin, plays an important role as a diagnostic investigation method in fungal keratitis. In the presented sample, the diagnosis of fungal keratitis was based on confocal microscopy findings in 43 cases (95.6%), as opposed to microbial analyses, which confirmed the diagnosis in 55.6% of patients. These findings are contradictory to those by Brasnu, who found that confocal microscopy offered equal sensitivity to the direct microscopic evaluation or microbial cultures [17] .
This study has several limitations. It provides a retrospective review of clinical data from a single centre as opposed to other papers published elsewhere in Europe which analysed data from several centres in one country. Nevertheless, it is the first study to analyse diagnosis, treatment and risk factors for fungal keratitis in Poland. A small number of patients were included in this observational study, although records covering a period of 5 years were collected. There is a need to continue research of aetiology, diagnostic and therapeutic management of fungal keratitis in Poland, as well as to compare data from a larger number of Polish ophthalmology departments.
CONCLUSION
Fungal keratitis poses a therapeutic challenge due to poor prognosis, low number of available treatments, and poor ocular penetration, as well as difficult and expensive diagnostic investigations. Despite unfavourable treatment outcomes, early accurate diagnosis followed by intensive antifungal treatment can prevent vision loss. 
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